Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells. They are designed to bind to specific targets, such as antigens on the surface of cancer cells, and are used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases.